Navigation Links
EXTENDED HEALTH: Noverca Enters the World of Healthcare
Date:4/8/2011

ROME, April 8, 2011 /PRNewswire/ -- Noverca – the first and currently only Italian 'Full MVNO' – has expanded its product offerings by announcing its presence in the Health and Wellness Sector.

An innovative telematic support model to support diabetes treatment has been developed and launched thanks to the long-term partnership between Acotel Group (Parent company of Noverca) and Fatebenefratelli Hospital. Davide Carnevale, Marketing & Sales Director at Noverca Italia, made the announcement during an Italy Expo Comm Italia 2011 press conference.

The telematic support product ensures a constant monitoring solution which enables patients to access their own health activity data on multiple channels including SMS, web, and Smartphone applications, and allows them to share the data with others, including doctors and family, resulting in heightened awareness and overall superior care."The partnership with Fatebenefratelli and the monitoring of diabetic patients is only the first step into the world of Healthcare," said Davide Carnevale.  "Moreover, we are ready to cover many other aspects of the Health and Wellness field."

At the heart of the Noverca system is the patent pending MiniMAU (Management Automation Unit) with embedded SIM Noverca 2.0.  The MiniMAU operates as a patient data access point to the GSM network and interfaces, via either IrDA, Bluetooth, or USB, with medical devices used by patients (e.g. glucometers) while communicating with the central platform.

The platform processes data relating to medical indicators of the patient and provides a full range of analyses useful for diagnostic and management purposes.  If requested, the platform will automatically send alerts via SMS and/or email, thereby permitting healthcare professionals to intervene and modify treatment in real time.

"In addition to our numerous mobile phone services," Davide Carnevale continues, "We will shortly be launching additional 2.0 services in the Health & Wellness, Security and Energy Control management sectors, as well as introducing a new and important concept of social networking."

About Acotel Group: Acotel Group, parent company to Flycell, JinnySoftware, Info2cell, & Noverca Italia, is a global provider of multimedia platforms and applications to mobile network operators and media companies around the world.  Through its customer base, Acotel services more than 35 million end users, and enabled 340 million paid text and multimedia messages in 2002.  Founded in 1992, Acotel operates in 20 countries and is publicly traded on the Milan Stock Exchange.Press OfficePress OfficeCast Adv. & CommunicationCommunication Area - Noverca Italiapressoffice@castadv.it

Alessandro MasciarelliTel.+ 39 06.33252983

alessandro.masciarelli@noverca.itAdriano Conti, Daniela Primerano, Stefania Caucci

Tel. + 39 06.61143000Who is Noverca Italia: Noverca Italia (www.noverca.it) is a company born out of the industrial cooperation starting in 2008 between the Acotel Group and the banking Group Intesa Sanpaolo.  The company is one of the main Italian virtual mobile operators and has always been distinguished by its ability to introduce services with high added value onto the market.


'/>"/>
SOURCE Noverca Italia
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tris Announces NDA Acceptance of Extended Release Carbinoxamine Oral Suspension for the Treatment of Allergies in Kids Two Years and Older
2. FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
3. Mylan Receives Approval for First-to-File Generic Sular® Extended-Release Tablets
4. New Study Shows Tapentadol Extended Release (ER) May Significantly Reduce Average Pain Intensity for Diabetic Patients Suffering From Painful Peripheral Neuropathy
5. Shionogi Inc. Announces Commercial Availability of KAPVAY™ (clonidine hydrochloride) Extended-Release Tablets for the Treatment of ADHD
6. Data Suggests Positive Pharmacokinetic Results From Phase I Research of Extended-Release Topiramate
7. Upsher-Smith Laboratories Announces Initiation of Open-Label Extension Study of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
8. Actavis Receives Approval of Zolpidem Tartrate Extended-Release Tablets, USP 6.25mg CIV in the U.S. with 180-Day Marketing Exclusivity
9. RoundTable Healthcare Partners Portfolio Company, Argon Medical Devices, Inc., Acquires Critical Care and Extended Dwell Catheter Product Platforms From BD
10. Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain
11. Abbotts SIMCOR ® ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)...  This report analyzes the worldwide markets for Chiral ... Products: Intermediates, Analytical, and Others. The End Use ... Agrochemicals. The report provides separate comprehensive analytics for the ... , and Rest of World. Annual estimates and ... Also, a six-year historic analysis is provided for these ...
(Date:2/24/2017)... Medivir AB (Nasdaq Stockholm: MVIR) ... Board of Directors that will be submitted to the ... representatives of the company,s three largest shareholders at the ... accepted a seat on the Nomination Committee, and the ... Nomination Committee was as follows:  ...
(Date:2/23/2017)... -- Visiomed, the French leader in medical grade ... the landscape of healthcare with their innovative use ... solutions. Recognizing the rising demand of self-monitoring alongside ... walls, Visiomed has launched BewellConnect, the most ground-breaking ... that is empowering the lives of patients. ...
Breaking Medicine Technology:
(Date:2/26/2017)... MICHIGAN (PRWEB) , ... February 25, 2017 , ... The ... Kim Jong-un, heightened awareness and concern over nerve agents and the deadly use of ... the human nervous system and how even small doses can be lethal. , Jay ...
(Date:2/26/2017)... Philadelphia, PA (PRWEB) , ... February 26, 2017 , ... ... products and services with Pay-For-Performance B2B Marketing. B2B Sellers will now only pay for ... , Robert Hennessey, the founder of IndustryArchive.Org, said, “Given the new reality that B2B ...
(Date:2/25/2017)... ... February 25, 2017 , ... FCPX users now have the ability to sharpen ... With ProSharpen Color users have total control over sharpening amount, sharpening radius, threshold, horizontal ... color spectrum tools users can visually see the color range effected with ease all ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of genetic variants ... points to eight genes that may explain why susceptibility to one of the disorders ... a study published today in the journal npj Schizophrenia. , “There is a ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Healthcare ... The Medical Center at Craig Ranch building at 8080 State Highway 121, Suite 210, ... District with easy access to Highway 121. , As the practice has grown, the ...
Breaking Medicine News(10 mins):